Sergio Augusto Lopes Souza

Prof. Dr. Sergio Augusto Lopes Souza

Radiology, UFRJ, Rio de Janeiro, Brazil
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2015 in Nature Reviews Gastroenterology & Hepatology
Verified
Journal Article
Closed access
HSHeitor S De Souza
Heitor S De Souza
CFClaudio Fiocchi
Claudio Fiocchi

23 August 2017 in Nature Reviews Gastroenterology & Hepatology
Verified
Journal Article
Closed access
PDF file
HSHeitor S De Souza
Heitor S De Souza
CFClaudio Fiocchi
Claudio Fiocchi
DIDimitrios Iliopoulos
Dimitrios Iliopoulos

Verified
Journal Article
Open access
PDF file
PSPatricia Teixeira Santana
Patricia Teixeira Santana
SRSiane L.B. Rosas
Siane L.B. Rosas
BRBeatriz Elias Ribeiro
Beatriz Elias Ribeiro
YMYgor Marinho
Ygor Marinho
HSHeitor S De Souza
Heitor S De Souza
Microbe–host communication is essential to maintain vital functions of a healthy host, and its disruption has been associated with several diseases, including Crohn’s disease and ulcerative colitis, the two major forms of inflammatory bowel disease (IBD). Although individual members of the intestinal microbiota have been associated with experimental IBD, identifying microorganisms that affect disease susceptibility and phenotypes in humans remains a considerable challenge. Currently, the lack of a definition between what is healthy and what is a dysbiotic gut microbiome limits research. Nevertheless, although clear proof-of-concept of causality is still lacking, there is an increasingly evident need to understand the microbial basis of IBD at the microbial strain, genomic, epigenomic, and functional levels and in specific clinical contexts. Recent information on the role of diet and novel environmental risk factors affecting the gut microbiome has direct implications for the immune response that impacts the development of IBD. The complexity of IBD pathogenesis, involving multiple distinct elements, suggests the need for an integrative approach, likely utilizing computational modeling of molecular datasets to identify more specific therapeutic targets.

1 December 1999 in Gut
Verified
Journal Article
Open access
PDF file
HSHeitor S De Souza
Heitor S De Souza
CEC C S Elia
C C S Elia
JSJ Spencer
J Spencer
TMT T MacDonald
T T MacDonald
BACKGROUND The interaction between leucocytes and vascular endothelial cells is essential for leucocyte migration into inflammatory sites. AIMS To study the local expression of the pairs of complementary molecules, α4β7/mucosal addressin cell adhesion molecule (MAdCAM-1) and OX40/OX40 ligand in the lamina propria of the colon and jejunum of patients with inflammatory bowel disease. METHODS Ten patients with active ulcerative colitis (UC), nine with active Crohn's disease (CD), and seven irritable bowel syndrome (IBS) controls were submitted to endoscopic and peroral jejunal biopsies. Specimens were immunostained by indirect alkaline phosphatase using antibodies against CD3, intercellular adhesion molecule (ICAM) 1, α4β7, MAdCAM-1, and OX40. An OX40-mouse-IgG fusion protein was used to detect OX40 ligand on frozen sections. Immunohistological analysis was carried out by optical microscopy using a computer assisted image analyser. RESULTS Colonic lamina propria of patients with CD and UC showed increased density of CD3+, α4β7+, and OX40+ cells compared with IBS controls. ICAM-1, MAdCAM-1, and OX40 ligand positive vessels were also increased compared with IBS controls. No significant difference was found in the density of any of these cells in the jejunal mucosa of patients compared with IBS controls. CONCLUSIONS The expression of MAdCAM-1 and OX40 ligand on gut endothelial and OX40+ cells is increased in sites of mucosal inflammation in patients with inflammatory bowel disease. No evidence was found for increased lamina propria T cells or increased vascular adhesion molecule expression in the proximal intestine of patients with distal inflammatory bowel disease.

2 July 2012 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
CPClaudia N Paiva
Claudia N Paiva
DFDaniel F Feijó
Daniel F Feijó
FDFabianno F Dutra
Fabianno F Dutra
VCVitor C Carneiro
Vitor C Carneiro
GFGuilherme B Freitas
Guilherme B Freitas
MBMarcelo T Bozza
Marcelo T Bozza
Oxidative damage contributes to microbe elimination during macrophage respiratory burst. Nuclear factor, erythroid-derived 2, like 2 (NRF2) orchestrates antioxidant defenses, including the expression of heme-oxygenase–1 (HO-1). Unexpectedly, the activation of NRF2 and HO-1 reduces infection by a number of pathogens, although the mechanism responsible for this effect is largely unknown. We studied Trypanosoma cruzi infection in mice in which NRF2/HO-1 was induced with cobalt protoporphyrin (CoPP). CoPP reduced parasitemia and tissue parasitism, while an inhibitor of HO-1 activity increased T. cruzi parasitemia in blood. CoPP-induced effects did not depend on the adaptive immunity, nor were parasites directly targeted. We also found that CoPP reduced macrophage parasitism, which depended on NRF2 expression but not on classical mechanisms such as apoptosis of infected cells, induction of type I IFN, or NO. We found that exogenous expression of NRF2 or HO-1 also reduced macrophage parasitism. Several antioxidants, including NRF2 activators, reduced macrophage parasite burden, while pro-oxidants promoted it. Reducing the intracellular labile iron pool decreased parasitism, and antioxidants increased the expression of ferritin and ferroportin in infected macrophages. Ferrous sulfate reversed the CoPP-induced decrease in macrophage parasite burden and, given in vivo, reversed their protective effects. Our results indicate that oxidative stress contributes to parasite persistence in host tissues and open a new avenue for the development of anti–T. cruzi drugs.

SJSilvia Rodrigues Jardim
Silvia Rodrigues Jardim
LSLucila Marieta Perrotta de Souza
Lucila Marieta Perrotta de Souza
HSHeitor S De Souza
Heitor S De Souza
The overall burden of cancer is rapidly increasing worldwide, reflecting not only population growth and aging, but also the prevalence and spread of risk factors. Gastrointestinal (GI) cancers, including stomach, liver, esophageal, pancreatic, and colorectal cancers, represent more than a quarter of all cancers. While smoking and alcohol use are the risk factors most commonly associated with cancer development, a growing consensus also includes dietary habits as relevant risk factors for GI cancers. Current evidence suggests that socioeconomic development results in several lifestyle modifications, including shifts in dietary habits from local traditional diets to less-healthy Western diets. Moreover, recent data indicate that increased production and consumption of processed foods underlies the current pandemics of obesity and related metabolic disorders, which are directly or indirectly associated with the emergence of various chronic noncommunicable conditions and GI cancers. However, environmental changes are not restricted to dietary patterns, and unhealthy behavioral features should be analyzed with a holistic view of lifestyle. In this review, we discussed the epidemiological aspects, gut dysbiosis, and cellular and molecular characteristics of GI cancers and explored the impact of unhealthy behaviors, diet, and physical activity on developing GI cancers in the context of progressive societal changes.